BizJournals.com - Nat'l Business News NeuBase Therapeutics said Monday that its special shareholder meeting to approve its dissolution adjourned without approval and will reconvene later this month after seeking more votes.\n more…
Bizjournals.com - Health Care News Pittsburgh-based biotech firm NeuBase Therapeutics, which is in the process of dissolving, will be removed from the Nasdaq stock exchange May 13.\n more…
Seeking Alpha - Healthcare NeuBase Therapeutics announces receipt of Nasdaq notice...\n more…
Globe Newswire PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ( NeuBase or the Company ) today reported that it received a notice (the Notice) on April 4, 2024 from...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.\nThe...\n more…
Bizjournals.com - Health Care News NeuBase Therapeutics will hold a special shareholder meeting May 13 to approve a plan to liquidate and dissolve the Pittsburgh biotech firm.\n more…